Introduction: Lymph node metastases (LNM) represent a proven prognostic factor for
biochemical recurrence (BCR)-free survival, metastatic free survival and overall survival in …

Patients with prostate cancer who have regional lymph node (LN) metastases face an
increased risk of death from disease and are therefore treated aggressively. Surgical LN …

In patients with prostate cancer, the presence of lymph node (LN) metastases is a critical
prognostic factor and is essential for treatment planning. Conventional cross-sectional …

Purpose: To prospectively evaluate the feasibility of magnetic resonance (MR) imaging with
ferumoxtran-10 in patients with prostate cancer to depict lymph node metastases outside the …

Accurate nodal staging at the time of diagnosis of prostate cancer is crucial in determining a
treatment plan for the patient. Pelvic lymph node dissection is the most reliable method, but …

Most metastatic lymph nodes in patients with prostate cancer go undetected by current
imaging techniques and limited pelvic lymph node dissection (PLND), as they are small and …

Conventional staging for prostate cancer (PCa) is performed for men diagnosed with
unfavorable-intermediate or higher risk disease. Computed tomography (CT) of the …

Nodal staging is important in prostate cancer treatment. While surgical lymph node
dissection is the classic method of determining whether lymph nodes harbor malignancy …

Knowledge on lymph node metastases is crucial for the prognosis and treatment of prostate
cancer patients. Conventional anatomic imaging often fails to differentiate benign from …

CONTEXT: Pelvic lymph node dissection (PLND) is considered the most reliable procedure
for the detection of lymph node metastases in prostate cancer (PCa); however, the …